NCT07721558

Brief Summary

This study aims to investigate whether using 50% FiO₂ during one-lung ventilation, compared with 100% FiO₂, reduces postoperative atelectasis in the non-dependent (healthy) lung of patients undergoing VATS right pulmonary lobectomy, based on individualized PEEP titration. This is a single-center, prospective, assessor- and patient-blinded randomized controlled trial. A total of 100 patients (50 per group, including a pilot phase of 10 per group) will be enrolled and randomized 1:1 to the high-oxygen group (FiO₂=100%) and the low-oxygen group (FiO₂=50%). The primary endpoint is the percentage of atelectasis volume in the non-operated lung relative to the total non-operated lung volume, assessed by CT at 90±10 minutes postoperatively.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
15mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 23, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 23, 2026

Status Verified

July 1, 2026

Enrollment Period

1.2 years

First QC Date

July 18, 2026

Last Update Submit

July 22, 2026

Conditions

Keywords

Inspired oxygen concentrationOne-lung ventilationLung recruitment maneuver

Outcome Measures

Primary Outcomes (1)

  • Non-operated lung atelectasis volume percentage

    Chest CT at 60±10 minutes after tracheal extubation

    CT scans were performed at 60 ± 10 minutes after tracheal extubation to assess the volume ratio of atelectasis in the contralateral lung.

Secondary Outcomes (7)

  • Incidence of postoperative pulmonary complications

    Postoperative days 1-3

  • QoR-15 quality of recovery score

    Postoperative days 1-3

  • Arterial blood gas analysis (oxygenation index)

    Multiple time points: preop room air; 5 minutes after one lung ventilation start; 1 hour after one lung ventilation ; pre-postanesthesia care unit discharge

  • Intraoperative oxygen saturationo

    Intraoperative (during one lung ventilation)

  • Oxygen concentration exposure burden

    Intraoperative (during one lung ventilation)

  • +2 more secondary outcomes

Study Arms (2)

High-Oxygen Group (FiO₂=100%)

ACTIVE COMPARATOR

FiO₂=100% throughout one-lung ventilation.

Procedure: High inspired oxygen concentration (FiO₂=100%) during one-lung ventilaion

Low-Oxygen Group (FiO₂=50%)

EXPERIMENTAL

Initial FiO₂=50% during one-lung ventilation (maintaining SpO₂≥92%) with individualized PEEP titration. If SpO₂\<92%, increase FiO₂ by 10% increments; if SpO₂\<90% and FiO₂ already at 100%, initiate rescue ventilation.

Procedure: Low inspired oxygen concentration (FiO₂=50%) during one-lung ventilation

Interventions

Ventilation with initial FiO₂=50% during one-lung ventilation, combined with individualized PEEP titration. Oxygen concentration is dynamically adjusted based on SpO₂; ventilation duration at each FiO₂ level and total oxygen exposure burden are recorded.

Low-Oxygen Group (FiO₂=50%)

Ventilation with FiO₂=100% throughout one-lung ventilation, combined with individualized PEEP titration (decremental PEEP titration selecting the highest PEEP corresponding to the lowest driving pressure).

High-Oxygen Group (FiO₂=100%)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years Elective thoracoscopic (VATS) right pulmonary lobectomy Anticipated one-lung ventilation duration \>1 hour ASA physical status I-III

You may not qualify if:

  • Previous lobectomy or lung volume reduction surgery Pre-existing significant atelectasis (large collapse on preoperative CT) Contraindications to PEEP: intracranial hypertension, bronchopleural fistula, hypovolemic shock, right heart failure, giant bullae, pneumothorax FiO₂ restrictions: preoperative continuous oxygen therapy or mechanical ventilation, moderate-severe COPD BMI ≥ 30 kg/m² Patient refusal to participate
  • Withdrawal Criteria / Major Protocol Deviations:
  • Surgery changed to simple wedge resection Severe pleural adhesions (found intraoperatively) Ventilation protocol interrupted Intraoperative blood loss \>500 ml Severe hypotension (MAP\<55 mmHg despite high-dose vasopressors) Unexpected non-thoracic surgical procedure FiO₂ exposure \<80% of planned time (experimental group) Postoperative CT not completed or image quality unusable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Central Study Contacts

Yi Feng, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients are blinded pre- and postoperatively; postoperative data collectors, CT readers, and biostatisticians are blinded to allocation; only the attending anesthesiologist is unblinded due to the nature of the intervention (setting FiO₂), but does not participate in data collection or outcome assessment
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Anesthesiology

Study Record Dates

First Submitted

July 18, 2026

First Posted

July 23, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

July 23, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be available upon reasonable request after publication

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Immediately following publication, for 3 years
Access Criteria
Researchers with a reasonable research purpose, subject to a data use agreement